|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.76 USD | +1.32% |
|
-8.41% | +23.05% |
| 06-30 | NovoCure Says Optune Pax Receives CE Mark for Locally Advanced Pancreatic Cancer Treatment | MT |
| 06-29 | NovoCure Limited(NasdaqGS:NVCR) added to Russell 2000 Value Benchmark | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.32% | -8.41% | -9.60% | +30.73% | +23.05% | -5.24% | -60.78% | -91.28% | +37.51% | 1.8B | |
| +0.23% | -0.13% | -0.42% | -4.67% | +1.92% | +34.04% | +1.08% | +26.39% | +428.05% | 12.44B | |
| +0.48% | +2.95% | +4.83% | +3.18% | -5.85% | +9.49% | +11.87% | -38.58% | +19.08% | 5.85B | |
| -4.68% | -5.64% | -2.48% | -3.45% | +17.99% | +51.49% | +25.92% | +24.95% | +200.09% | 5.96B | |
| +4.42% | +3.73% | +3.87% | +2.37% | - | - | - | - | - | 4.22B | |
| -1.55% | +10.23% | -0.49% | -20.62% | -16.14% | -30.22% | +15.83% | +4.68% | - | 4.25B | |
| +2.24% | +3.50% | +3.62% | -18.56% | -29.60% | -22.41% | -24.23% | -32.17% | +18.36% | 3.96B | |
| -1.40% | -1.86% | +2.43% | +32.22% | +26.15% | -2.92% | +252.29% | -39.69% | - | 1.89B | |
| +1.66% | +2.00% | +2.51% | +6.10% | +54.47% | +55.96% | -2.86% | +28.30% | +166.86% | 1.54B | |
| +1.62% | -3.39% | -1.75% | -30.03% | -21.45% | -16.39% | -46.30% | -77.48% | - | 1.29B | |
| +2.63% | +5.58% | +11.22% | +27.10% | -38.88% | -20.42% | -5.36% | -52.39% | +1,114.45% | 1.09B | |
| +1.66% | +1.42% | +13.29% | +18.22% | -13.13% | +1.24% | -35.31% | -40.62% | - | 750M | |
| +1.89% | +2.23% | -3.37% | -37.96% | -35.42% | -38.12% | -50.51% | -69.93% | - | 774M | |
| +3.24% | -5.00% | +8.04% | +12.35% | -1.79% | +194.82% | +12.08% | -39.00% | - | 623M | |
| -7.38% | -11.25% | -4.22% | -0.87% | -1.99% | -3.85% | -35.38% | -23.56% | - | 488M | |
| -0.94% | -1.86% | +92.12% | +104.52% | +266.47% | +383.97% | +448.92% | -3.65% | - | 434M | |
| +1.96% | -1.88% | -11.19% | -21.00% | -28.85% | -8.06% | +10.27% | +4.58% | -57.36% | 433M | |
| -0.69% | -2.45% | -11.53% | -13.34% | -4.82% | -7.65% | -52.23% | - | - | 400M | |
| +1.29% | -1.53% | -2.88% | -4.58% | -10.59% | +2.75% | +36.61% | - | - | 371M | |
| +3.67% | -0.67% | -6.34% | -32.96% | -30.81% | -37.68% | +8.78% | -5.84% | - | 357M | |
| Average | +0.57% | -1.29% | +4.38% | +2.44% | +7.93% | +28.46% | +26.88% | -25.02% | +240.88% | 2.45B | |
| Weighted average by Cap. | +0.18% | -0.09% | +1.55% | -1.75% | +1.40% | +18.68% | +13.97% | -7.53% | +248.49% |
- Stock Market
- Stocks
- NVCR Stock
- Sector NovoCure Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
